drugset
drugset / Trial / NCT00219583

Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

NCT00219583 ↗

Phase 2/3 Completed 460 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

Assessment of efficacy and safety UK-390,957.

Timeline

Start
2004-08
Primary completion
2005-06
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject UK-390,957 Small molecule — —

Indications

premature ejaculation